QIAGEN Price to Sales Ratio 2010-2024 | QGEN

Historical PS ratio values for QIAGEN (QGEN) over the last 10 years. The current P/S ratio for QIAGEN as of October 03, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
QIAGEN P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-10-03 43.54 5.05
2024-06-30 41.09 $8.62 4.77
2024-03-31 42.99 $8.53 5.04
2023-12-31 44.77 $8.61 5.20
2023-09-30 41.75 $8.56 4.87
2023-06-30 46.42 $8.68 5.35
2023-03-31 47.35 $8.84 5.36
2022-12-31 51.41 $9.55 5.38
2022-09-30 42.56 $9.98 4.27
2022-06-30 48.66 $10.09 4.82
2022-03-31 50.52 $10.30 4.91
2021-12-31 57.30 $10.02 5.72
2021-09-30 53.28 $9.94 5.36
2021-06-30 49.88 $9.69 5.15
2021-03-31 50.20 $9.12 5.51
2020-12-31 54.48 $8.23 6.62
2020-09-30 53.88 $7.60 7.09
2020-06-30 44.13 $7.23 6.11
2020-03-31 42.89 $6.96 6.16
2019-12-31 34.85 $6.85 5.09
2019-09-30 33.99 $6.75 5.03
2019-06-30 41.80 $6.67 6.27
2019-03-31 41.94 $6.64 6.32
2018-12-31 35.52 $6.71 5.29
2018-09-30 39.05 $6.48 6.03
2018-06-30 37.28 $6.17 6.04
2017-09-30 32.47 $6.09 5.33
2017-06-30 34.57 $5.94 5.82
2017-03-31 29.87 $5.84 5.12
2016-12-31 30.00 $5.78 5.19
2016-09-30 29.38 $5.72 5.14
2016-06-30 23.35 $5.76 4.05
2016-03-31 23.92 $5.74 4.17
2018-03-31 33.31 $5.89 5.65
2015-12-31 29.60 $5.71 5.18
2015-09-30 27.64 $5.74 4.82
2015-06-30 26.54 $6.07 4.37
2015-03-31 26.98 $6.12 4.41
2014-12-31 25.12 $6.25 4.02
2017-12-31 31.89 $6.12 5.21
2014-09-30 24.38 $5.96 4.09
2014-06-30 26.18 $5.89 4.45
2014-03-31 22.58 $5.86 3.85
2013-12-31 25.49 $5.81 4.39
2013-09-30 22.91 $5.75 3.98
2013-06-30 21.32 $5.67 3.76
2013-03-31 22.57 $5.60 4.03
2012-12-31 19.43 $5.58 3.48
2012-09-30 19.82 $5.54 3.58
2012-06-30 17.88 $5.49 3.25
2012-03-31 16.67 $5.38 3.10
2011-12-31 14.78 $5.23 2.83
2011-09-30 14.81 $5.01 2.96
2011-06-30 20.36 $4.94 4.12
2011-03-31 21.47 $4.85 4.43
2010-12-31 20.93 $4.87 4.30
2010-09-30 18.99 $4.88 3.89
2010-06-30 20.58 $4.98 4.13
2010-03-31 24.61 $5.08 4.84
2009-12-31 23.91 $5.04 4.74
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $9.936B $1.965B
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $170.591B 17.07
Vertex Pharmaceuticals (VRTX) United States $117.062B 0.00
Regeneron Pharmaceuticals (REGN) United States $111.843B 26.41
Bristol Myers Squibb (BMY) United States $109.885B 39.56
Gilead Sciences (GILD) United States $104.791B 17.91
CSL (CSLLY) Australia $95.815B 0.00
GSK (GSK) United Kingdom $79.523B 9.22
Alnylam Pharmaceuticals (ALNY) United States $34.602B 0.00
Argenex SE (ARGX) Netherlands $32.469B 0.00
BioNTech SE (BNTX) Germany $28.484B 0.00
Biogen (BIIB) United States $26.915B 11.36
Moderna (MRNA) United States $23.475B 0.00
BeiGene (BGNE) Cayman Islands $22.716B 0.00
Illumina (ILMN) United States $21.722B 148.22
Genmab (GMAB) Denmark $15.483B 19.34
BioMarin Pharmaceutical (BMRN) United States $12.942B 38.29
Incyte (INCY) United States $12.912B 838.00
Vaxcyte (PCVX) United States $12.398B 0.00
Exact Sciences (EXAS) United States $12.271B 0.00
Insmed (INSM) United States $12.270B 0.00
Bio-Techne Corp (TECH) United States $11.740B 45.96
Sarepta Therapeutics (SRPT) United States $11.326B 258.17
Bio-Rad Laboratories (BIO.B) United States $9.332B 30.92
Legend Biotech (LEGN) United States $8.712B 0.00
Roivant Sciences (ROIV) United Kingdom $8.290B 0.00
Ascendis Pharma (ASND) Denmark $8.211B 0.00
Repligen (RGEN) United States $7.787B 118.84
Revolution Medicines (RVMD) United States $7.706B 0.00
Halozyme Therapeutics (HALO) United States $7.655B 20.14
Intra-Cellular Therapies (ITCI) United States $7.634B 0.00
Exelixis (EXEL) United States $7.485B 23.02
Viking Therapeutics (VKTX) United States $7.103B 0.00
Nuvalent (NUVL) United States $6.707B 0.00
Cytokinetics (CYTK) United States $6.555B 0.00
Zealand Pharma (ZLDPF) Denmark $5.957B 0.00
Blueprint Medicines (BPMC) United States $5.579B 0.00
Avidity Biosciences (RNA) United States $5.166B 0.00
Krystal Biotech (KRYS) United States $5.054B 338.33
Ultragenyx Pharmaceutical (RARE) United States $4.946B 0.00
Alkermes (ALKS) Ireland $4.672B 16.40
ADMA Biologics Inc (ADMA) United States $4.561B 75.27
Biohaven (BHVN) United States $4.410B 0.00
Axsome Therapeutics (AXSM) United States $4.331B 0.00
Immunovant (IMVT) United States $4.286B 0.00
Arcellx (ACLX) United States $4.096B 0.00
Denali Therapeutics (DNLI) United States $4.040B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.819B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.477B 0.00
Apellis Pharmaceuticals (APLS) United States $3.417B 0.00
Merus (MRUS) Netherlands $3.401B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.322B 0.00
Amicus Therapeutics (FOLD) United States $3.132B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.008B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.970B 0.00
Iovance Biotherapeutics (IOVA) United States $2.731B 0.00
Guardant Health (GH) United States $2.682B 0.00
Kymera Therapeutics (KYMR) United States $2.681B 0.00
Protagonist Therapeutics (PTGX) United States $2.612B 16.92
Bavarian Nordic (BVNRY) Denmark $2.600B 14.04
Geron (GERN) United States $2.598B 0.00
Apogee Therapeutics (APGE) United States $2.558B 0.00
Twist Bioscience (TWST) United States $2.507B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $2.503B 0.00
Edgewise Therapeutics (EWTX) United States $2.497B 0.00
IDEAYA Biosciences (IDYA) United States $2.471B 0.00
Zai Lab (ZLAB) China $2.452B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.442B 81.78
Structure Therapeutics (GPCR) United States $2.419B 0.00
CG Oncology (CGON) United States $2.412B 0.00
Myriad Genetics (MYGN) United States $2.400B 0.00
ImmunityBio (IBRX) United States $2.368B 0.00
SpringWorks Therapeutics (SWTX) United States $2.364B 0.00
Novavax (NVAX) United States $2.309B 0.00
Janux Therapeutics (JANX) United States $2.304B 0.00
Keros Therapeutics (KROS) United States $2.248B 0.00
Vera Therapeutics (VERA) United States $2.220B 0.00
Neumora Therapeutics (NMRA) United States $2.168B 0.00
Celldex Therapeutics (CLDX) United States $2.044B 0.00
Vericel (VCEL) United States $2.027B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.976B 17.83
Akero Therapeutics (AKRO) United States $1.920B 0.00
Beam Therapeutics (BEAM) United States $1.891B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.890B 0.00
Ligand Pharmaceuticals (LGND) United States $1.868B 31.75
Galapagos (GLPG) Belgium $1.865B 0.00
NeoGenomics (NEO) United States $1.810B 0.00
Intellia Therapeutics (NTLA) United States $1.793B 0.00
Certara (CERT) United States $1.768B 57.84
MannKind (MNKD) United States $1.765B 64.20
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.731B 0.00
Fortrea Holdings (FTRE) United States $1.710B 53.00
Arvinas (ARVN) United States $1.681B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.590B 0.00
NovoCure (NVCR) Jersey $1.573B 0.00
Belite Bio (BLTE) United States $1.558B 0.00
Viridian Therapeutics (VRDN) United States $1.526B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.526B 0.00
Disc Medicine (IRON) United States $1.491B 0.00
Dynavax Technologies (DVAX) United States $1.466B 101.73
Rocket Pharmaceuticals (RCKT) United States $1.462B 0.00
Spyre Therapeutics (SYRE) United States $1.445B 0.00
Longboard Pharmaceuticals (LBPH) United States $1.402B 0.00
Arcus Biosciences (RCUS) United States $1.400B 0.00
Nurix Therapeutics (NRIX) United States $1.396B 0.00
Kura Oncology (KURA) United States $1.393B 0.00
Bicara Therapeutics (BCAX) $1.232B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.228B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.211B 0.00
ANI Pharmaceuticals (ANIP) United States $1.195B 16.23
Arcutis Biotherapeutics (ARQT) United States $1.189B 0.00
Praxis Precision Medicines (PRAX) United States $1.177B 0.00
Cogent Biosciences (COGT) United States $1.155B 0.00
Gyre Therapeutics (GYRE) United States $1.144B 0.00
Tyra Biosciences (TYRA) United States $1.140B 0.00
Mesoblast (MESO) Australia $1.090B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.082B 0.00
WAVE Life Sciences (WVE) Singapore $1.060B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.055B 0.00
Travere Therapeutics (TVTX) United States $1.044B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.038B 0.00
Vir Biotechnology (VIR) United States $1.002B 0.00
AnaptysBio (ANAB) United States $0.961B 0.00
Sana Biotechnology (SANA) United States $0.945B 0.00
Cullinan Therapeutics (CGEM) United States $0.933B 0.00
Prothena (PRTA) Ireland $0.904B 0.00
Applied Therapeutics (APLT) United States $0.903B 0.00
IGM Biosciences (IGMS) United States $0.884B 0.00
Immatics (IMTX) Germany $0.876B 0.00
Zymeworks (ZYME) United States $0.866B 0.00
ArriVent BioPharma (AVBP) United States $0.860B 0.00
MiMedx (MDXG) United States $0.840B 23.83
Immunome (IMNM) United States $0.807B 0.00
Dianthus Therapeutics (DNTH) United States $0.806B 0.00
CARGO Therapeutics (CRGX) United States $0.802B 0.00
Replimune (REPL) United States $0.799B 0.00
Castle Biosciences (CSTL) United States $0.785B 0.00
MBX Biosciences (MBX) $0.780B 0.00
Liquidia Technologies (LQDA) United States $0.775B 0.00
Adaptive Biotechnologies (ADPT) United States $0.746B 0.00
Zenas BioPharma (ZBIO) $0.745B 0.00
Tango Therapeutics (TNGX) United States $0.739B 0.00
AbCellera Biologics (ABCL) Canada $0.731B 0.00
Arbutus Biopharma (ABUS) United States $0.727B 0.00
89BIO (ETNB) United States $0.704B 0.00
Erasca (ERAS) United States $0.692B 0.00
Pliant Therapeutics (PLRX) United States $0.676B 0.00
Cytek Biosciences (CTKB) United States $0.676B 0.00
Avid Bioservices (CDMO) United States $0.674B 0.00
Oric Pharmaceuticals (ORIC) United States $0.673B 0.00
Rapport Therapeutics (RAPP) United States $0.671B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.667B 0.00
CureVac (CVAC) Germany $0.663B 0.00
Olema Pharmaceuticals (OLMA) United States $0.662B 0.00
Annexon (ANNX) United States $0.656B 0.00
Abivax SA (ABVX) France $0.651B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Mineralys Therapeutics (MLYS) United States $0.642B 0.00
Astria Therapeutics (ATXS) United States $0.638B 0.00
Humacyte (HUMA) United States $0.630B 0.00
Stoke Therapeutics (STOK) United States $0.622B 0.00
LENZ Therapeutics (LENZ) United States $0.618B 0.00
Entrada Therapeutics (TRDA) United States $0.612B 5.55
Y-mAbs Therapeutics (YMAB) United States $0.603B 0.00
Nuvation Bio (NUVB) United States $0.583B 0.00
Neurogene (NGNE) United States $0.577B 0.00
Terns Pharmaceuticals (TERN) United States $0.577B 0.00
Pharming Group (PHAR) Netherlands $0.574B 0.00
Scholar Rock Holding (SRRK) United States $0.566B 0.00
Revance Therapeutics (RVNC) United States $0.551B 0.00
Celcuity (CELC) United States $0.549B 0.00
Allogene Therapeutics (ALLO) United States $0.546B 0.00
Q32 Bio (QTTB) United States $0.516B 0.00
Oculis Holding AG (OCS) Switzerland $0.512B 0.00
Third Harmonic Bio (THRD) United States $0.509B 0.00
ACELYRIN, INC (SLRN) United States $0.490B 0.00
Cartesian Therapeutics (RNAC) United States $0.488B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.483B 0.00
Anavex Life Sciences (AVXL) United States $0.475B 0.00
Alumis (ALMS) United States $0.474B 0.00
Emergent Biosolutions (EBS) United States $0.473B 0.00
PureTech Health (PRTC) United States $0.471B 0.00
CorMedix Inc (CRMD) United States $0.463B 0.00
REGENXBIO (RGNX) United States $0.462B 0.00
Contineum Therapeutics (CTNM) United States $0.454B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.451B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.448B 0.00
Tectonic Therapeutic (TECX) United States $0.437B 0.00
Aura Biosciences (AURA) United States $0.433B 0.00
Absci (ABSI) United States $0.433B 0.00
Foghorn Therapeutics (FHTX) United States $0.414B 0.00
Alector (ALEC) United States $0.411B 0.00
Prime Medicine (PRME) United States $0.409B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.396B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.394B 0.00
Northwest Biotherapeutics (NWBO) United States $0.393B 0.00
GRAIL (GRAL) United States $0.390B 0.00
MaxCyte (MXCT) United States $0.381B 0.00
Anika Therapeutics (ANIK) United States $0.374B 180.57
Artiva Biotherapeutics (ARTV) United States $0.374B 0.00
C4 Therapeutics (CCCC) United States $0.370B 0.00
Biomea Fusion (BMEA) United States $0.365B 0.00
Fate Therapeutics (FATE) United States $0.355B 0.00
ITeos Therapeutics (ITOS) United States $0.354B 0.00
Instil Bio (TIL) United States $0.340B 0.00
GH Research (GHRS) Ireland $0.340B 0.00
AC Immune (ACIU) Switzerland $0.335B 0.00
Nautilus Biotechnology (NAUT) United States $0.330B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.329B 0.00
Voyager Therapeutics (VYGR) United States $0.327B 21.39
Inozyme Pharma (INZY) United States $0.317B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.314B 0.00
XOMA Royalty (XOMA) United States $0.309B 0.00
Kamada (KMDA) Israel $0.297B 19.15
ADC Therapeutics SA (ADCT) Switzerland $0.295B 0.00
PepGen (PEPG) United States $0.293B 0.00
Urogen Pharma (URGN) United States $0.290B 0.00
Sutro Biopharma (STRO) United States $0.289B 0.00
EnGene Holdings (ENGN) Canada $0.287B 0.00
Atea Pharmaceuticals (AVIR) United States $0.281B 0.00
TScan Therapeutics (TCRX) United States $0.280B 0.00
Zura Bio (ZURA) United States $0.279B 0.00
Abeona Therapeutics (ABEO) United States $0.276B 0.00
Nkarta (NKTX) United States $0.275B 0.00
Alto Neuroscience (ANRO) United States $0.275B 0.00
Ocugen (OCGN) United States $0.273B 0.00
Rezolute (RZLT) United States $0.271B 0.00
Alpha Teknova (TKNO) United States $0.270B 0.00
Design Therapeutics (DSGN) United States $0.267B 0.00
MeiraGTx Holdings (MGTX) United States $0.266B 0.00
GENFIT S.A (GNFT) France $0.265B 0.00
Editas Medicine (EDIT) United States $0.264B 0.00
ChromaDex (CDXC) United States $0.263B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.262B 0.00
Compass Therapeutics (CMPX) United States $0.261B 0.00
Opthea (OPT) Australia $0.260B 0.00
Solid Biosciences (SLDB) United States $0.259B 0.00
Mersana Therapeutics (MRSN) United States $0.248B 0.00
Prima BioMed (IMMP) Australia $0.247B 0.00
Jasper Therapeutics (JSPR) United States $0.247B 0.00
Poseida Therapeutics (PSTX) United States $0.247B 0.00
2seventy Bio (TSVT) United States $0.245B 0.00
Amarin (AMRN) Ireland $0.244B 0.00
Precigen (PGEN) United States $0.233B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.229B 0.00
Fulcrum Therapeutics (FULC) United States $0.229B 0.00
Gossamer Bio (GOSS) United States $0.228B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.228B 0.00
UniQure (QURE) Netherlands $0.222B 0.00
Codexis (CDXS) United States $0.220B 0.00
Trevi Therapeutics (TRVI) United States $0.219B 0.00
ScPharmaceuticals (SCPH) United States $0.217B 0.00
Inhibrx Biosciences (INBX) United States $0.215B 0.00
Candel Therapeutics (CADL) United States $0.215B 0.00
XBiotech (XBIT) United States $0.215B 0.00
Cabaletta Bio (CABA) United States $0.211B 0.00
Black Diamond Therapeutics (BDTX) United States $0.207B 0.00
Kyverna Therapeutics (KYTX) United States $0.199B 0.00
23andMe Holding (ME) United States $0.191B 0.00
DiaMedica Therapeutics (DMAC) United States $0.188B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.185B 0.00
Innate Pharma S.A (IPHA) France $0.184B 0.00
Greenwich LifeSciences (GLSI) United States $0.180B 0.00
Eton Pharmaceuticals (ETON) United States $0.179B 0.00
BioStem Technologies (BSEM) $0.169B 26.49
Molecular Partners AG (MOLN) Switzerland $0.168B 0.00
Sangamo Therapeutics (SGMO) United States $0.165B 0.00
Scilex Holding (SCLX) United States $0.164B 0.00
Caribou Biosciences (CRBU) United States $0.162B 0.00
Compugen (CGEN) Israel $0.159B 0.00
Generation Bio (GBIO) United States $0.159B 0.00
Adverum Biotechnologies (ADVM) United States $0.151B 0.00
Tenaya Therapeutics (TNYA) United States $0.150B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.149B 0.00
Repare Therapeutics (RPTX) Canada $0.147B 0.00
Inovio Pharmaceuticals (INO) United States $0.147B 0.00
PDS Biotechnology (PDSB) United States $0.146B 0.00
Ventyx Biosciences (VTYX) United States $0.146B 0.00
Lifecore Biomedical (LFCR) United States $0.145B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.144B 0.00
Immunic (IMUX) United States $0.143B 0.00
Seres Therapeutics (MCRB) United States $0.142B 0.00
Actuate Therapeutics (ACTU) United States $0.137B 0.00
Kodiak Sciences (KOD) United States $0.137B 0.00
Vigil Neuroscience (VIGL) United States $0.135B 0.00
ATyr Pharma (ATYR) United States $0.132B 0.00
Elutia (ELUT) United States $0.130B 0.00
Akoya Biosciences (AKYA) United States $0.126B 0.00
Sagimet Biosciences (SGMT) United States $0.126B 0.00
Oncobiologics (OTLK) United States $0.124B 0.00
Adherex Technologies (FENC) United States $0.124B 113.00
Puma Biotechnology (PBYI) United States $0.124B 13.26
Rani Therapeutics Holdings (RANI) United States $0.123B 0.00
Coherus BioSciences (CHRS) United States $0.120B 0.00
Seer (SEER) United States $0.119B 0.00
Cardiff Oncology (CRDF) United States $0.118B 0.00
Adicet Bio (ACET) United States $0.117B 0.00
Nuvectis Pharma (NVCT) United States $0.115B 0.00
Invivyd (IVVD) United States $0.115B 0.00
BioAtla (BCAB) United States $0.114B 0.00
Verastem (VSTM) United States $0.111B 0.00
Cellectis S.A (CLLS) France $0.110B 0.00
Skye Bioscience (SKYE) United States $0.109B 0.00
X4 Pharmaceuticals (XFOR) United States $0.106B 0.00
I-Mab (IMAB) China $0.106B 0.00
INmune Bio (INMB) United States $0.105B 0.00
Annovis Bio (ANVS) United States $0.105B 0.00
Coya Therapeutics (COYA) United States $0.104B 0.00
Benitec Biopharma (BNTC) United States $0.104B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.101B 0.00
Adagene (ADAG) China $0.101B 0.00
Bluebird Bio (BLUE) United States $0.100B 0.00
Clearside Biomedical (CLSD) United States $0.099B 0.00
Agenus (AGEN) United States $0.098B 0.00
Checkpoint Therapeutics (CKPT) United States $0.098B 0.00
MediciNova (MNOV) United States $0.097B 0.00
Inventiva S.A (IVA) France $0.096B 0.00
FibroBiologics (FBLG) United States $0.093B 0.00
BeyondSpring (BYSI) United States $0.093B 0.00
BioHarvest Sciences (CNVCF) Canada $0.092B 0.00
InflaRx (IFRX) Germany $0.092B 0.00
ALX Oncology Holdings (ALXO) United States $0.091B 0.00
CytomX Therapeutics (CTMX) United States $0.088B 8.07
Werewolf Therapeutics (HOWL) United States $0.088B 0.00
HilleVax (HLVX) United States $0.087B 0.00
Connect Biopharma Holdings (CNTB) United States $0.081B 0.00
Chimerix (CMRX) United States $0.081B 0.00
Ikena Oncology (IKNA) United States $0.081B 0.00
Genelux (GNLX) United States $0.080B 0.00
CervoMed (CRVO) United States $0.080B 0.00
Ovid Therapeutics (OVID) United States $0.080B 0.00
Genenta Science S.p.A (GNTA) Italy $0.080B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.080B 0.00
VistaGen Therapeutics (VTGN) United States $0.080B 0.00
Galena Biopharma (SLS) United States $0.080B 0.00
Cidara Therapeutics (CDTX) United States $0.075B 0.00
Aileron Therapeutics (ALRN) United States $0.075B 0.00
Renovaro (RENB) United States $0.074B 0.00
Adlai Nortye (ANL) Cayman Islands $0.074B 0.00
Oncolytics Biotech (ONCY) Canada $0.072B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.071B 0.00
Immuneering (IMRX) United States $0.070B 0.00
Boundless Bio (BOLD) United States $0.070B 0.00
Spero Therapeutics (SPRO) United States $0.070B 3.15
Rapt Therapeutics (RAPT) United States $0.069B 0.00
Precision BioSciences (DTIL) United States $0.069B 0.00
IO Biotech (IOBT) Denmark $0.067B 0.00
Entera Bio (ENTX) Israel $0.066B 0.00
DBV Technologies S.A (DBVT) France $0.066B 0.00
LakeShore Biopharma (LSB) China $0.063B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.063B 0.00
Leap Therapeutics (LPTX) United States $0.063B 0.00
Omega Therapeutics (OMGA) United States $0.063B 0.00
TELA Bio (TELA) United States $0.062B 0.00
ZIVO Bioscience (ZIVO) United States $0.061B 0.00
Shattuck Labs (STTK) United States $0.061B 0.00
Imunon (IMNN) United States $0.061B 0.00
Kezar Life Sciences (KZR) United States $0.060B 0.00
Allakos (ALLK) United States $0.060B 0.00
Celularity (CELU) United States $0.059B 0.00
Enzo Biochem (ENZ) United States $0.058B 0.00
Kronos Bio (KRON) United States $0.058B 0.00
Aerovate Therapeutics (AVTE) United States $0.057B 0.00
Theratechnologies (THTX) Canada $0.056B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.054B 0.00
Elicio Therapeutics (ELTX) United States $0.053B 0.00
Lexaria Bioscience (LEXX) Canada $0.052B 0.00
Syros Pharmaceuticals (SYRS) United States $0.052B 0.00
Semper Paratus Acquisition (TVGN) United States $0.052B 0.00
Earth Science Tech (ETST) United States $0.052B 0.00
Affimed (AFMD) Germany $0.050B 0.00
Intensity Therapeutics (INTS) United States $0.050B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.050B 0.00
HOOKIPA Pharma (HOOK) United States $0.049B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.049B 0.00
Aadi Bioscience (AADI) United States $0.047B 0.00
CalciMedica (CALC) United States $0.047B 0.00
Rallybio (RLYB) United States $0.046B 0.00
Vor Biopharma (VOR) $0.045B 0.00
VTv Therapeutics (VTVT) United States $0.043B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.042B 0.00
Estrella Immunopharma (ESLA) United States $0.040B 0.00
Cue Biopharma (CUE) United States $0.040B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.039B 0.00
Lantern Pharma (LTRN) United States $0.039B 0.00
Bionano Genomics (BNGO) United States $0.038B 0.00
Passage Bio (PASG) United States $0.037B 0.00
Immix Biopharma (IMMX) United States $0.037B 0.00
Fortress Biotech (FBIO) United States $0.037B 0.00
NextCure (NXTC) United States $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
Atara Biotherapeutics (ATRA) United States $0.035B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.035B 0.00
Clene (CLNN) United States $0.034B 0.00
Ocuphire Pharma (OCUP) United States $0.034B 0.00
Promis Neurosciences (PMN) Canada $0.033B 0.00
Quince Therapeutics (QNCX) United States $0.032B 0.00
Xilio Therapeutics (XLO) United States $0.032B 0.00
Ocean Biomedical (OCEA) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Elevation Oncology (ELEV) United States $0.031B 0.00
Eyenovia (EYEN) United States $0.030B 0.00
Curis (CRIS) United States $0.030B 0.00
Equillium (EQ) United States $0.030B 0.00
Lumos Pharma (LUMO) United States $0.030B 0.00
Pluri (PLUR) Israel $0.030B 0.00
BRIACELL THERAP (BCTX) Canada $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Dyadic (DYAI) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
Aligos Therapeutics (ALGS) United States $0.026B 0.00
Longeveron (LGVN) United States $0.026B 0.00
BioAffinity Technologies (BIAF) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
RenovoRx (RNXT) United States $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
KALA BIO (KALA) United States $0.024B 0.00
UNITY Biotechnology (UBX) United States $0.024B 0.00
Gritstone Bio (GRTS) United States $0.024B 0.00
SAB Biotherapeutics (SABS) United States $0.023B 0.00
BioXcel Therapeutics (BTAI) United States $0.022B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
Vincerx Pharma (VINC) United States $0.021B 0.00
Orgenesis (ORGS) United States $0.021B 0.00
Cyclo Therapeutics (CYTH) United States $0.020B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.019B 0.00
Biora Therapeutics (BIOR) United States $0.019B 0.00
Spruce Biosciences (SPRB) United States $0.018B 0.00
Beyond Air (XAIR) United States $0.018B 0.00
Synlogic (SYBX) United States $0.018B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.018B 0.00
Cognition Therapeutics (CGTX) United States $0.017B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.017B 0.00
Evaxion Biotech (EVAX) Denmark $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
HCW Biologics (HCWB) United States $0.017B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Monopar Therapeutics (MNPR) United States $0.016B 0.00
IMMURON (IMRN) Australia $0.016B 0.00
Cara Therapeutics (CARA) United States $0.015B 0.00
Aytu BioPharma (AYTU) United States $0.015B 0.00
Apollomics (APLM) United States $0.015B 0.00
Cingulate (CING) United States $0.015B 0.00
Aprea Therapeutics (APRE) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
NKGen Biotech (NKGN) United States $0.014B 0.00
Galecto (GLTO) Denmark $0.013B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.013B 0.00
IN8bio (INAB) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
Evogene (EVGN) Israel $0.012B 0.00
Cadrenal Therapeutics (CVKD) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
Novogen (KZIA) Australia $0.011B 0.00
Tenax Therapeutics (TENX) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Kintara Therapeutics (KTRA) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
ABVC BioPharma (ABVC) United States $0.008B 0.00
Aptose Biosciences (APTO) Canada $0.008B 0.00
Carmell (CTCX) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Forte Biosciences (FBRX) United States $0.007B 0.00
Purple Biotech (PPBT) Israel $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
BioCardia (BCDA) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.005B 0.00
NuCana (NCNA) United Kingdom $0.005B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.005B 0.00
Eterna Therapeutics (ERNA) United States $0.005B 0.00
Quantum Biopharma (QNTM) Canada $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Vaccinex (VCNX) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.00
AquaBounty Technologies (AQB) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Notable Labs (NTBL) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
Trevena (TRVN) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
Elevai Labs (ELAB) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Bionomics (BNOX) Australia $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Ensysce Biosciences (ENSC) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Entero Therapeutics (ENTO) United States $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
GENPREX (GNPX) United States $0.001B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00